Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

eNAMPT is a plasma biomarker of COVID-19 severity and ARDS progression linked to increased immune effector cell expression

The utility of plasma eNAMPT measurements as a potential COVID-19 biomarker linked to ARDS progression and disease severity is explored and NAMPT expression in immune effector cells that correlates with COVID-19 severity and lethality is identified.

Jason Canizales Galaviz, Amir Khan, B. Tourki et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.